Vasamed, Inc. (VSMD)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2005 | 4.67 Million USD | -21.81% |
| 2004 | 5.97 Million USD | 129.61% |
| 2003 | 2.6 Million USD | -14.24% |
| 2002 | 3.03 Million USD | -11.16% |
| 2001 | 3.41 Million USD | -20.59% |
| 2000 | 4.3 Million USD | -40.64% |
| 1999 | 7.24 Million USD | -38.06% |
| 1998 | 11.7 Million USD | 6.36% |
| 1997 | 11 Million USD | 4.76% |
| 1996 | 10.5 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2006 Q1 | 1.24 Million USD | 15.69% |
| 2006 Q2 | 1.28 Million USD | 3.93% |
| 2006 Q3 | 1.39 Million USD | 7.83% |
| 2005 Q2 | 1.09 Million USD | 24.38% |
| 2005 Q4 | 1.07 Million USD | -34.24% |
| 2005 Q1 | 877.44 Thousand USD | 3.16% |
| 2005 FY | 4.67 Million USD | -21.81% |
| 2005 Q3 | 1.63 Million USD | 49.48% |
| 2004 Q4 | 850.58 Thousand USD | -37.81% |
| 2004 Q1 | 895.37 Thousand USD | 52.13% |
| 2004 FY | 5.97 Million USD | 129.61% |
| 2004 Q3 | 1.36 Million USD | -52.22% |
| 2004 Q2 | 2.86 Million USD | 219.75% |
| 2003 FY | 2.6 Million USD | -14.24% |
| 2003 Q1 | 412.32 Thousand USD | -46.44% |
| 2003 Q4 | 588.54 Thousand USD | -37.18% |
| 2003 Q3 | 936.88 Thousand USD | 40.84% |
| 2003 Q2 | 665.23 Thousand USD | 61.34% |
| 2002 Q4 | 769.87 Thousand USD | 7.09% |
| 2002 Q2 | 535.51 Thousand USD | -29.58% |
| 2002 FY | 3.03 Million USD | -11.16% |
| 2002 Q3 | 718.9 Thousand USD | 34.25% |
| 2002 Q1 | 760.41 Thousand USD | -36.86% |
| 2001 Q3 | 786.74 Thousand USD | 28.99% |
| 2001 FY | 3.41 Million USD | -20.59% |
| 2001 Q1 | 927.01 Thousand USD | 52.22% |
| 2001 Q2 | 609.92 Thousand USD | -34.21% |
| 2001 Q4 | 1.2 Million USD | 53.08% |
| 2000 FY | 4.3 Million USD | -40.64% |
| 2000 Q4 | 608.97 Thousand USD | -44.64% |
| 2000 Q3 | 1.09 Million USD | -13.46% |
| 2000 Q2 | 1.27 Million USD | -3.82% |
| 2000 Q1 | 1.32 Million USD | -1.91% |
| 1999 Q4 | 1.34 Million USD | -15.79% |
| 1999 Q2 | 1.6 Million USD | -40.74% |
| 1999 Q3 | 1.6 Million USD | 0.0% |
| 1999 Q1 | 2.7 Million USD | -6.9% |
| 1999 FY | 7.24 Million USD | -38.06% |
| 1998 Q1 | 2.8 Million USD | 27.27% |
| 1998 FY | 11.7 Million USD | 6.36% |
| 1998 Q4 | 2.9 Million USD | -6.45% |
| 1998 Q3 | 3.1 Million USD | 3.33% |
| 1998 Q2 | 3 Million USD | 7.14% |
| 1997 Q4 | 2.2 Million USD | -18.52% |
| 1997 FY | 11 Million USD | 4.76% |
| 1997 Q1 | 3.2 Million USD | 14.29% |
| 1997 Q2 | 3.3 Million USD | 3.13% |
| 1997 Q3 | 2.7 Million USD | -18.18% |
| 1996 Q3 | 2.8 Million USD | -6.67% |
| 1996 Q2 | 3 Million USD | 36.36% |
| 1996 Q4 | 2.8 Million USD | 0.0% |
| 1996 FY | 10.5 Million USD | 0.0% |
| 1996 Q1 | 2.2 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | -63.199% |
| Ansell Limited | 495.5 Million USD | 99.057% |
| Ansell Limited | 495.5 Million USD | 99.057% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | 94.357% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -169.993% |
| Psykey, Inc. | 1.21 Million USD | -285.084% |
| ConvaTec Group Plc | 910.31 Million USD | 99.487% |
| ConvaTec Group Plc | 872.5 Million USD | 99.464% |
| Encision Inc. | 3.77 Million USD | -23.729% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -3195.17% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -4150.77% |
| Innovative MedTech Inc. | 6.09 Million USD | 23.382% |
| LifePoint, Inc. | 7.42 Million USD | 37.056% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | 26.399% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -446.54% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -543.533% |
| Reflect Scientific, Inc. | 1.06 Million USD | -339.308% |
| SmileDirectClub, Inc. | 517 Million USD | 99.096% |
| Sector 10, Inc. | 39.84 Thousand USD | -11628.024% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | 99.93% |
| SheerVision, Inc. | 2.33 Million USD | -100.414% |
| United Health Products, Inc. | 2.42 Million USD | -92.575% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | -82.407% |
| Yubo International Biotech Limited | 1.25 Million USD | -271.493% |